CORRECTION: Sandoz lays foundation stone for new biosimilars centre
corrects currency to USD
Please note that the values of the investments are in US dollars and NOT in euros, as incorrectly stated in the 1st and 5th paragraph. A corrected copy follows.
Sandoz lays foundation stone for new biosimilars centre
Ljubljana, 19 April - The Swiss pharma giant Sandoz lay the foundation stone for a new biosimilars development centre in Ljubljana on Friday. The USD 90 million investment will create around 200 jobs and is expected to be completed in 2026.
The rest of this news item is available to subscribers.
The news item consists of 1.348 characters (without spaces) or 244 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.